Skip to content

Prevalence of Digestive Carriage of Integrons

Prevalence of Digestive Carriage of Integrons to Resistance in Two Populations in Limousin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01985217
Acronym
APIHA
Enrollment
492
Registered
2013-11-15
Start date
2009-08-31
Completion date
2013-12-31
Last updated
2013-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Resistance to Antimicrobial

Brief summary

Bacterial resistance to antimicrobials is an increasing problem. Doctors occasionally face genuine therapeutic dead-ends, when attempting to cure nosocomial infections and, more and more frequently, community-acquired infections. Mastering antimicrobial resistance diffusion is nowadays a major Public Health issue.

Detailed description

Struggling against bacterial resistance to antimicrobials lays on three main measures: * individual and collective hygiene. * proper antibiotics practices, which could help reduce antibiotic selective pressure. * better understanding of bacterial resistance mechanisms and resistance gene transfer between bacteria. Integrons, gene capture and expression systems, are recognised as major players in resistance gene transfer, which accounts for the greater part of resistance emergence and dissemination. Integrons are typically described in Gram negative bacteria, isolated in man, environmental settings and animals. They encode resistances to nearly every class of antimicrobials. A strong link between integrons and resistance to multiple antibiotic compounds has been described and integron detection is a relevant indicator of resistance to multiple antibiotics. The investigators project offers to study the impact of antibiotics on the frequency of integron intestinal carriage in the Limousin region and the genetic communities between the two groups. This study will use an innovative real-time PCR technique to detect integrons directly in the sample without using traditional culture-based techniques. The investigators hope to detect new integron-carriers, notably patients for whom integrons are borne by non or poorly cultivable bacteria. Stool samples will be taken from two groups of subjects : 246 intensive-care unit patients under high antibiotic selective pressure, compared with 246 healthy individuals representative of the community, under a more usual selective pressure. In both groups, antibiotic consumption will be fully documented.

Interventions

None listed

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adults \> 18 years * patients Hospitalized in intensive care unit for at least 48 hours, including one antibiotic was found at least in the background (\<3 months). * patients followed by the Department for Work and Health for bacteriological examination of stool * possible information about antibiotic therapy provided

Design outcomes

Primary

MeasureTime frameDescription
Positive PCRday 1* From the conventional, a subject is found integrons carrying resistance when the PCR is positive on at least one bacterial strain previously isolated. * According to the direct approach, a subject is considered integrons carrying resistance when the PCR is positive in the DNA extracted directly from feces or broth enrichment.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026